Related references
Note: Only part of the references are listed.Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration
Elisabeth H. Thijssen et al.
NATURE MEDICINE (2020)
Robust, reproducible and quantitative analysis of thousands of proteomes by micro-flow LC-MS/MS
Yangyang Bian et al.
NATURE COMMUNICATIONS (2020)
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
Sebastian Palmqvist et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer's disease
Nicolas R. Barthelemy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Development and Technical Validation of an Immunoassay for the Detection of APP669-711 (Aβ-3-40) in Biological Samples
Hans W. Klafki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Top-down proteomics: challenges, innovations, and applications in basic and clinical research
Kyle A. Brown et al.
EXPERT REVIEW OF PROTEOMICS (2020)
Best practices and benchmarks for intact protein analysis for top-down mass spectrometry
Daniel P. Donnelly et al.
NATURE METHODS (2019)
High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis
Suzanne E. Schindler et al.
NEUROLOGY (2019)
Quality control in mass spectrometry-based proteomics
Wout Bittremieux et al.
MASS SPECTROMETRY REVIEWS (2018)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
High performance plasma amyloid-β biomarkers for Alzheimer's disease
Akinori Nakamura et al.
NATURE (2018)
Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease
Leonardo Iaccarino et al.
NEUROIMAGE-CLINICAL (2018)
Quantitation of Intact Proteins in Human Plasma Using Top-Down Parallel Reaction Monitoring-MS
Yuchao Chen et al.
ANALYTICAL CHEMISTRY (2018)
Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis
Vitaliy Ovod et al.
ALZHEIMERS & DEMENTIA (2017)
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
Clifford R. Jack et al.
NEUROLOGY (2016)
PET Imaging of Tau Deposition in the Aging Human Brain
Michael Schoell et al.
NEURON (2016)
Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease
Matthew R. Brier et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation
Sylvia Villeneuve et al.
BRAIN (2015)
Targeted Proteomic Quantification on Quadrupole-Orbitrap Mass Spectrometer
Sebastien Gallien et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
Association of Plasma β-Amyloid Level and Cognitive Reserve With Subsequent Cognitive Decline
Kristine Yaffe et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Alzheimer's Disease: The Challenge of the Second Century
David M. Holtzman et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
Sandip Ray et al.
NATURE MEDICINE (2007)
Simultaneous measurement of β-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology
A Olsson et al.
CLINICAL CHEMISTRY (2005)
Share Paper
